These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24034523)

  • 1. Authors' response to: Statins in pregnancy: safety and perspectives of therapeutic applications.
    Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
    BJOG; 2013 Oct; 120(11):1440. PubMed ID: 24034523
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins in pregnancy: safety and perspectives of therapeutic applications.
    Vlachadis N; Tsamadias V; Economou E
    BJOG; 2013 Oct; 120(11):1439-40. PubMed ID: 24034522
    [No Abstract]   [Full Text] [Related]  

  • 3. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
    Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
    BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes.
    Taguchi N; Rubin ET; Hosokawa A; Choi J; Ying AY; Moretti ME; Koren G; Ito S
    Reprod Toxicol; 2008 Oct; 26(2):175-7. PubMed ID: 18640262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcomes following maternal exposure to statins: A systematic review and meta-analysis.
    Karadas B; Uysal N; Erol H; Acar S; Koc M; Kaya-Temiz T; Koren G; Kaplan YC
    Br J Clin Pharmacol; 2022 Sep; 88(9):3962-3976. PubMed ID: 35639354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal exposure to statins and risk for birth defects: a case-series approach.
    Petersen EE; Mitchell AA; Carey JC; Werler MM; Louik C; Rasmussen SA;
    Am J Med Genet A; 2008 Oct; 146A(20):2701-5. PubMed ID: 18792975
    [No Abstract]   [Full Text] [Related]  

  • 7. Statins: beware during pregnancy.
    Prescrire Int; 2006 Feb; 15(81):18-9. PubMed ID: 16548110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of statin use during pregnancy: a systematic review.
    Kazmin A; Garcia-Bournissen F; Koren G
    J Obstet Gynaecol Can; 2007 Nov; 29(11):906-908. PubMed ID: 17977494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperlipoproteinemia in pregnancy].
    Abel T; Blázovics A; Kemény M; Lengyel G
    Orv Hetil; 2011 May; 152(19):753-7. PubMed ID: 21498165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcomes after maternal use of thiocolchicoside: A case series.
    Kaplan YC; Keskin-Arslan E; Küçüksolak G; Akyol F; Karadas B; Görgel SN; Kaya-Temiz T
    Reprod Toxicol; 2018 Mar; 76():103-108. PubMed ID: 29378258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins in pregnancy: new safety data are reassuring, but suspension of treatment is still advisable.
    Haramburu F; Daveluy A; Miremont-Salamé G
    BMJ; 2015 Mar; 350():h1484. PubMed ID: 25784692
    [No Abstract]   [Full Text] [Related]  

  • 12. The fetal safety of statins: a systematic review and meta-analysis.
    Zarek J; Koren G
    J Obstet Gynaecol Can; 2014 Jun; 36(6):506-509. PubMed ID: 24927189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of maternal toxicity in lovastatin-induced developmental toxicity.
    Lankas GR; Cukierski MA; Wise LD
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethylene oxide exposure and risk of spontaneous abortion, preterm birth, and postterm birth.
    Olsen G; Lucas L; Teta J
    Epidemiology; 1997 Jul; 8(4):465-6. PubMed ID: 9209871
    [No Abstract]   [Full Text] [Related]  

  • 15. Statins in pregnancy.
    Morton S; Thangaratinam S
    Curr Opin Obstet Gynecol; 2013 Dec; 25(6):433-40. PubMed ID: 24126785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of lipid-lowering agents (statins) during pregnancy.
    Hosokawa A; Bar-Oz B; Ito S
    Can Fam Physician; 2003 Jun; 49():747-9. PubMed ID: 12836860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin has deleterious effects on human first trimester placental explants.
    Kenis I; Tartakover-Matalon S; Cherepnin N; Drucker L; Fishman A; Pomeranz M; Lishner M
    Hum Reprod; 2005 Oct; 20(10):2866-72. PubMed ID: 15958395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can statins prevent pregnancy complications?
    Girardi G
    J Reprod Immunol; 2014 Mar; 101-102():161-167. PubMed ID: 24012117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical inquiries. What precautions should we use with statins for women of childbearing age?
    Patel C; Edgerton L; Flake D; Smits A
    J Fam Pract; 2006 Jan; 55(1):75-7. PubMed ID: 16388775
    [No Abstract]   [Full Text] [Related]  

  • 20. Statins are detrimental to human placental development and function; use of statins during early pregnancy is inadvisable.
    Forbes K; Hurst LM; Aplin JD; Westwood M; Gibson JM
    J Cell Mol Med; 2008 Dec; 12(6A):2295-6. PubMed ID: 19120704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.